KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
Rules and regulation often change as industries evolve. These publications keep you updated on regulatory and compliance issues in China.
Submit an enquiry about our services, industry practices, or get in touch with one of our professionals.